ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD) has started an upward trend since last wednesday and soared up more than 40 % in just 3 trading sessions and up 54 % in last 5 trading sessions. The move looks stronger with higher than average volumes. There is no specific announcements about the developments, but according to our knowledge small biotech companies are in news because they have secured funding, acquired patent, clinical development or might be take over target by big pharmaceuticals. We suggest to keep an eye on the stock regarding any announcements about something positive. It is touching new 52 week high since last 3 trading sessions. As soon as we heard something, we will update immediately.Stay tuned to news board. Last news from the company was on 1st april 2011 that it is extending its collaboration with Allergan Inc for drug discovery.ACADIA Pharmaceuticals Inc ( NASDAQ:ACAD) soars more than 40 % in last 3 trading session without any announcements
ACADIA Pharmaceuticals Inc. ( NASDAQ:ACAD) has started an upward trend since last wednesday and soared up more than 40 % in just 3 trading sessions and up 54 % in last 5 trading sessions. The move looks stronger with higher than average volumes. There is no specific announcements about the developments, but according to our knowledge small biotech companies are in news because they have secured funding, acquired patent, clinical development or might be take over target by big pharmaceuticals. We suggest to keep an eye on the stock regarding any announcements about something positive. It is touching new 52 week high since last 3 trading sessions. As soon as we heard something, we will update immediately.Stay tuned to news board. Last news from the company was on 1st april 2011 that it is extending its collaboration with Allergan Inc for drug discovery.
0 comments